Related Experiment Video

Updated: May 9, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Antiproliferative activity of new benzimidazole derivatives

Katarzyna Błaszczak-Świątkiewicz1, Paulina Olszewska, Elżbieta Mikiciuk-Olasik

  • 1Department of Pharmaceutical Chemistry and Drug Analysis, Medical University, Lodz, Poland.

Acta Biochimica Polonica
|July 27, 2013
PubMed

Insights

New benzimidazole derivatives show potent anticancer activity, particularly under hypoxic conditions. Compounds 8 and 14 demonstrated significant cytotoxicity and induced apoptosis in lung cancer cells, highlighting their potential as hypoxia-targeted cancer therapies.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Developing novel anticancer agents is crucial for improving patient outcomes.
  • Tumor hypoxia is a significant challenge in cancer treatment, often leading to resistance.
  • Benzimidazole derivatives represent a promising scaffold for drug discovery.

Purpose of the Study:

  • To synthesize and evaluate novel benzimidazole derivatives for anticancer activity.
  • To investigate the efficacy of these compounds under both normoxic and hypoxic conditions.
  • To determine the mechanism of cell death induced by the most active compounds.

Main Methods:

  • In vitro synthesis of benzimidazole derivatives.
  • Cell proliferation assays (WST-1) on selected tumor cell lines under normoxia and hypoxia.
  • Apoptosis assays (caspase 3/7) to assess cell death pathways.
  • Cytotoxicity assessment and calculation of hypoxia/normoxia coefficients.

Main Results:

  • Four compounds (7, 8, 13, 11) exhibited significant antiproliferative effects.
  • Compounds 8, 14, and 11 showed specific activity under hypoxic conditions.
  • Compound 8 was highly cytotoxic to A549 lung adenocarcinoma cells in hypoxia.
  • Compound 14 demonstrated a hypoxia/normoxia coefficient comparable to reference drugs.

Conclusions:

  • The synthesized benzimidazole derivatives possess promising anticancer properties.
  • Compounds 8 and 14 are particularly effective against lung cancer cells under hypoxia.
  • These compounds induce cancer cell death via apoptosis, suggesting therapeutic potential for hypoxia-driven cancers.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...